8. Ries, L. A. G., M. P. Eisner, C. L. Kosary, et al., “SEER Cancer Statistics Review 1975-2001,” National Cancer Institute, Bethesda, MD, 2004.

   9. Institut de Veille Sanitaire, “Estimations Nationales.”

   10. Ries, Eisner, Kosary, et al., “SEER Cancer Statistics Review 1975-2001.”

   11. Ferlay, J., F. Bray, P. Piesci, et al., eds., WHO International Agency for Research on Cancer (IARC), IARC Cancer Epidemiology Database, Globocan 2000, Cancer Incidence, Mortality and Prevalence Worldwide (Lyon, France: IARC Press, 2000).

   12. King, M-C., J. H. Marks, J. B. Mandell, et al., “Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2,” Science 302, no. 5645 (2003): 643-46.

   13. Institut de Veille Sanitaire, “Estimations Nationales.”

   14. Rosenberg, C. E., The Cholera Years: The United States in 1832, 1849, and 1866 (Chicago, IL: University of Chicago Press, 1962).

   15. Steingraber, S., Living Downstream: A Scientist’s Personal Investigation of Cancer and the Environment (New York: Vintage Books, 1998).

   16. Davis, D., The Secret History of the War on Cancer (New York: Basic Books, 2007).

   17. Waterhouse, J., C. Muir, K. Shamnugaratnam, et al., eds., Cancer Incidence in Five Continents, vol. IV (Lyon, France: IARC-W.H.O., 1982).

   18. Sasco, A. J., “Migration and Cancer,” Revue de Médecine Interne 10, no. 4 (1989): 341-48.

   19. Davis, The Secret History of the War on Cancer.

   20. Waterhouse and Shamnugaratnam, Cancer Incidence in Five Continents.

   21. Stewart, B. W., and P. Kleihues, eds., World Cancer Report (Lyon, France: W.H.O. IARC Press, 2003).

   22. National Cancer Institute, Executive Summary of Cancer Etiology Think Tank (Bethesda, MD: National Cancer Institute, 2004).

   23. Eaton, S. B., and M. Konner, “Paleolithic Nutrition: A Consideration of Its Nature and Current Implications,” New England Journal of Medicine 312, no. 5 (1985): 283-89.

   24. Cordain, L., S. Eaton, A. Sebastian, et al., “Origins and Evolution of the Western Diet: Health Implications for the 21st Century,” American Journal of Clinical Nutrition 81, no. 2 (2005): 341-54.

   25. Ibid.

   26. Grothey, A., W. Voigt, C. Schober, et al., “The Role of Insulin-Like Growth Factor I and Its Receptor in Cell Growth, Transformation, Apoptosis, and Chemoresis tance in Solid Tumors,” Journal of Cancer Research & Clinical Oncology 125, no. 3-4 (1999): 166-73.

   27. Long, L., R. Navab, and P. Brodt, “Regulation of the Mr 72,000 Type IV Collagenase by the Type I Insulin-Like Growth Factor Receptor,” Cancer Research 58m, no. 15 (1998): 3243-47.

   28. Dunn, S. E., R. A. Hardman, F. W. Kari, et al., “Insulin-Like Growth Factor 1 (IGF-1) Alters Drug Sensitivity of HBL 100 Human Breast Cancer Cells by Inhibition of Apoptosis Induced by Diverse Anticancer Drugs,” Cancer Research 57, no. 13 (1997): 2687-93.

   29. Cordain, L., S. Lindeberg, M. Hurtado, et al., “Acne Vulgaris: A Disease of Western Civilization,” Archives of Dermatology 138, no. 12 (2002): 1584-90.

   30. Smith, R., N. Mann, A. Braue, et al., “The Effect of a Low Glycemic Load, High Protein Diet on Hormonal Markers of Acne,” Asia Pacific Journal of Clinical Nutrition 14 (supp.) (2005): S43.

   31. Smith, R., N. Mann, A. Braue, et al., “Low Glycemic Load, High Protein Diet Lessens Facial Acne Severity,” Asia Pacific Journal of Clinical Nutrition 14 (supp.) (2005): S97.

   32. Santisteban, G. A., J. T. Ely, E. E. Hamel, et al., “Glycemic Modulation of Tumor Tolerance in a Mouse Model of Breast Cancer,” Biochemical & Biopbysical Research Communications 132, no. 3 (1985): 1174-79.

   33. Parkin, D., F. Bay, J. Ferlay, et al., “Global Cancer Statistics, 2002,” CA: A Cancer Journal for Clinicians 55 (2005): 74-108.

   34. Weiderpass, E., G. Gridley, I. Persson, et al., “Risk of Endometrial and Breast Cancer in Patients with Diabetes Mellitus,” International Journal of Cancer 71, no. 3 (1997): 360-63.

   35. Hankinson, S. E., W. C. Willett, G. A. Colditz, et al., “Circulating Concentrations of Insulin-Like Growth Factor-I and Risk of Breast Cancer,” Lancet 351, no. 9113 (1998): 1393-96.

   36. Chan, J. M., M. J. Stampfer, E. Giovannucci, et al., “Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study,” Science 279, no. 5350 (1998): 563-66.

Перейти на страницу:

Похожие книги